CollPlant Biotechnologies (CLGN) Retained Earnings (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Retained Earnings of -$124.8 million for Q4 2025, down 2.64% on a QoQ basis from -$121.6 million in Q3 2025, and down 10.14% year-over-year from -$138.9 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Retained Earnings (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Retained Earnings history runs 9 years deep, the most recent figure standing at -$124.8 million for Q4 2025.
- Quarterly Retained Earnings fell 10.14% year-over-year to -$124.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$124.8 million (down 10.14% YoY) and the FY2025 annual result came in at -$124.8 million, down 10.14% from the prior year.
- Retained Earnings was -$124.8 million for Q4 2025 at CollPlant Biotechnologies, down from -$121.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$62.9 million in Q1 2021 and bottomed at -$124.8 million in Q4 2025.
- A 5-year average of -$93.0 million and a median of -$92.1 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings advanced 8.64% — and 2022, when it decreased 23.61%.
- CollPlant Biotechnologies' Retained Earnings stood at -$72.8 million in 2021, then dropped by 23.25% to -$89.7 million in 2022, then retreated by 7.82% to -$96.7 million in 2023, then dropped by 17.17% to -$113.4 million in 2024, then retreated by 10.14% to -$124.8 million in 2025.
- Business Quant data shows CLGN's Retained Earnings at -$124.8 million in Q4 2025, -$121.6 million in Q3 2025, and -$118.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -124.84 Mn |
| Sep 30, 2025 | -121.63 Mn |
| Jun 30, 2025 | -118.15 Mn |
| Dec 31, 2024 | -113.35 Mn |
| Sep 30, 2024 | -109.47 Mn |
| Jun 30, 2024 | -105.15 Mn |
| Mar 31, 2024 | -100.94 Mn |
| Dec 31, 2023 | -96.74 Mn |
| Sep 30, 2023 | -92.05 Mn |
| Jun 30, 2023 | -87.68 Mn |
| Mar 31, 2023 | -93.44 Mn |
| Dec 31, 2022 | -89.72 Mn |
| Sep 30, 2022 | -85.32 Mn |
| Jun 30, 2022 | -80.94 Mn |
| Mar 31, 2022 | -76.66 Mn |
| Dec 31, 2021 | -72.80 Mn |
| Sep 30, 2021 | -69.03 Mn |
| Jun 30, 2021 | -65.95 Mn |
| Mar 31, 2021 | -62.91 Mn |
| Dec 31, 2020 | -73.03 Mn |